サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1394000

欧州の構造的心臓市場の2028年までの予測- 地域別分析- 製品別、手技別、エンドユーザー別

Europe Structural Heart Market Forecast to 2028 - Regional Analysis - by Product, Procedure, and End User
出版日: | 発行: The Insight Partners | ページ情報: 英文 146 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.91円
欧州の構造的心臓市場の2028年までの予測- 地域別分析- 製品別、手技別、エンドユーザー別
出版日: 2023年10月09日
発行: The Insight Partners
ページ情報: 英文 146 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州の構造的心臓市場は、2022年の32億1,380万米ドルから2028年には49億925万米ドルに成長すると予測されています。2022年から2028年までのCAGRは7.3%と推定されます。

革新的な構造的心臓サービスの利用可能性が欧州の構造的心臓市場を後押し

技術的に進歩した製品や治療サービスが利用できるようになったことで、外科医、医師、その他のヘルスケアプロバイダーは、患者に優れたサービスを提供できるようになり、患者が最適な生活の質を維持できるようになっています。技術革新はヘルスケア施設だけにとどまらず、患者が治療施設から利益を得られるように設計されたプログラムにも及んでいます。心臓病は複雑であり、その治療が成功するかどうかは、以前は不可能とされていた治療法を現実のものとする技術革新にかかっています。心臓病治療の情勢は、構造的発明から外科的弁治療に至るまで、過去数十年にわたり画期的な技術革新を経験してきました。構造的心臓市場の企業は、血管疾患、不整脈、心臓弁膜症など、さまざまな心臓疾患に対する幅広いソリューション・ポートフォリオを提供しています。現在、医師は遠隔監視装置を用いて患者を監視することにより不整脈を管理することができ、それによってさまざまな構造的心臓疾患を治療することができます。

食品医薬品局（FDA）は、特定の患者グループに限定したさまざまな治療法を承認しています。例えば、革新的な構造的心臓サービスを提供するPremier Health社は、肥大型心筋症に対するアルコール中隔アブレーション治療を提供しています。この治療には主にカテーテルを用いた技術が用いられています。バルーン弁形成術は、硬く狭い心臓弁を広げるための経カテーテル的アプローチであり、心房中隔欠損症の経カテーテル修復術は、手術をせずに心臓の左心房と右心房の間の開口部を閉鎖するもので、サービスプロバイダーはさらに多くのサービスを提供しています。セントラケアの心臓・血管センターは、EchoPixel社のTrue3DとHTGプリ・プランニング・ソフトウェアを使用しました。このソフトウェアは複合現実感機能を提供し、構造的心臓治療チームが、物理的に触れたり造影剤や放射線を浴びたりすることなく、患者の解剖学的構造のリアルタイムのホログラフィック・ヴァージョンと対話することを可能にします。

構造的心臓プログラムの革新的な技術とテクニックは、患者にとって最良の結果をもたらす質の高いケアを提供するために特別に設計されており、合併症が少なく、回復に要する時間が短く、長続きする利点があります。このような技術は、構造的な心臓疾患に苦しむより多くの患者を惹きつける可能性が高く、最終的にはサービスの利点が予測期間中の市場の成長を高める可能性が高いです。

欧州の構造的心臓市場の概要

欧州の構造的心臓市場は、ドイツ、英国、フランス、イタリア、スペイン、その他欧州に区分されます。同地域は構造的心臓市場で大きな市場シェアを占めています。欧州の構造的心臓市場は、高齢者人口の大幅な増加、CVD罹患率の上昇、同地域の市場参入企業による革新的製品の発売などの要因により、予測期間中に大幅な成長が見込まれています。また、欧州では心臓病治療薬の承認数が増加しています。さらに、市場各社はより多くの顧客層を獲得し、市場の競争力を維持するため、さまざまな取り組みを行っています。これらすべての要因が、同地域の市場成長に拍車をかけています。

欧州の構造的心臓市場の2028年までの収益と予測（金額）

欧州の構造的心臓市場のセグメンテーション

欧州の構造的心臓市場は、製品、手技、エンドユーザー、国別に区分されます。

製品別では、欧州の構造的心臓市場はオクルーダー、環状形成リング、心臓弁バルーン、その他に区分されます。オクルーダセグメントは、2022年の欧州の構造的心臓市場で最大のシェアを占めています。

手技別に見ると、欧州の構造的心臓市場は心臓弁狭窄症、心臓弁逆流症、左心房付属器閉鎖不全症に区分されます。心臓弁狭窄症セグメントが2022年の欧州の構造的心臓市場で最大のシェアを占めています。

エンドユーザーに基づき、欧州の構造的心臓市場は病院、外来手術センター、心臓センターに区分されます。病院セグメントが2022年の欧州の構造的心臓市場で最大のシェアを占めました。

国別では、欧州の構造的心臓市場はドイツ、英国、フランス、イタリア、スペイン、その他欧州に区分されます。2022年の欧州の構造的心臓市場はドイツが独占しています。

Abbott Laboratories、Medtronic Plc、Boston Scientific Corp、Artivion Inc、Edwards Lifesciences Corp、Lepu Medical Technology Beijing Co Ltd、Braile Biomedical Industry, Commerce and Representations、Micro Interventional Devices Incなどは、欧州の構造的心臓市場で事業を展開している大手企業です。

目次

第1章 イントロダクション

第2章 欧州の構造的心臓市場-主要なポイント

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 欧州の構造的心臓市場-市場情勢

  • 概観
  • PEST分析
    • 欧州PEST分析
  • 専門家の見解

第5章 欧州の構造的心臓市場：主要市場力学

  • 市場促進要因
    • 革新的な構造的心臓サービスの利用可能性
    • 心血管疾患症例の増加とトレーニングプログラム
  • 主な市場抑制要因
    • 手術費用の高さ
    • 構造的心臓装置に関する厳しい規制
  • 主な市場機会
    • 構造的心臓における人工知能の利用拡大
  • 今後の動向
    • 構造的心臓デバイス分野における技術の進歩
  • 影響分析

第6章 欧州の構造的心臓市場-欧州分析

  • 欧州の構造的心臓市場の収益予測と分析

第7章 欧州の構造的心臓市場-2028年までの収益と予測-製品別

  • 欧州の構造的心臓市場：製品別、収益シェア、2021年・2028年
  • オクルーダー
  • 環状形成リング
  • 心臓弁バルーン
  • その他

第8章 欧州の構造的心臓市場：手技別、2028年までの収益と予測

  • 欧州の構造的心臓市場の手技別、収益シェア、2021年および2028年
  • 心臓弁狭窄症
  • 心臓弁逆流
  • 左心房付属器閉鎖

第9章 欧州の構造的心臓市場の2028年までの収益と予測：エンドユーザー別

  • 欧州の構造的心臓市場のエンドユーザー別、収益シェア、2021年および2028年
  • 病院
  • 外来手術センター
  • 心臓センター

第10章 欧州の構造的心臓市場：2028年までの収益と予測：国別分析

第11章 欧州の構造的心臓市場-業界情勢

  • 成長戦略

第12章 欧州の構造的心臓市場企業プロファイル

  • Abbott Laboratories
  • Medtronic Plc
  • Boston Scientific Corp
  • Artivion Inc
  • Edwards Lifesciences Corp
  • Lepu Medical Technology Beijing Co Ltd
  • Aran Biomedical Teoranta
  • Corcym UK Ltd

第13章 付録

図表

List Of Tables

  • Table 1. Germany Europe Structural Heart Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 2. Germany Europe Structural Heart Market, by Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. Germany Europe Structural Heart Market, by Heart Valve Stenosis Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. Germany Europe Structural Heart Market, by Heart Valve Regurgitation Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. Germany Europe Structural Heart Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. UK Europe Structural Heart Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. UK Europe Structural Heart Market, by Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. UK Europe Structural Heart Market, by Heart Valve Stenosis Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. UK Europe Structural Heart Market, by Heart Valve Regurgitation Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. UK Europe Structural Heart Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. France Europe Structural Heart Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. France Europe Structural Heart Market, by Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. France Europe Structural Heart Market, by Heart Valve Stenosis Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. France Europe Structural Heart Market, by Heart Valve Regurgitation Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 15. France Europe Structural Heart Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. Italy Europe Structural Heart Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Italy Europe Structural Heart Market, by Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 18. Italy Europe Structural Heart Market, by Heart Valve Stenosis Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. Italy Europe Structural Heart Market, by Heart Valve Regurgitation Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 20. Italy Europe Structural Heart Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 21. Spain Europe Structural Heart Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 22. Spain Europe Structural Heart Market, by Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 23. Spain Europe Structural Heart Market, by Heart Valve Stenosis Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 24. Spain Europe Structural Heart Market, by Heart Valve Regurgitation Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 25. Spain Europe Structural Heart Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 26. Rest of Europe Structural Heart Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 27. Rest of Europe Structural Heart Market, by Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 28. Rest of Europe Structural Heart Market, by Heart Valve Stenosis Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 29. Rest of Europe Structural Heart Market, by Heart Valve Regurgitation Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 30. Rest of Europe Structural Heart Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 31. Recent Organic Growth Strategies in Europe Structural Heart Market
  • Table 32. Glossary of Terms

List Of Figures

  • Figure 1. Europe Structural Heart Market Segmentation
  • Figure 2. Europe Structural Heart Market, by Country
  • Figure 3. Europe Structural Heart Market Overview
  • Figure 4. Occluders Segment Held Largest Share of Product Segment in Europe Structural Heart Market
  • Figure 5. Europe: PEST Analysis
  • Figure 6. Europe Experts' Opinion
  • Figure 7. Europe Structural Heart Market: Impact Analysis of Drivers and Restraints
  • Figure 8. Europe Structural Heart Market - Revenue Forecast and Analysis - 2019-2028
  • Figure 9. Europe Structural Heart Market Revenue Share, by Product 2021 & 2028 (%)
  • Figure 10. Occluders: Europe Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 11. Annuloplasty Rings: Europe Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 12. Heart Valve Balloons: Europe Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 13. Others: Europe Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 14. Europe Structural Heart Market Revenue Share, by Procedure 2021 & 2028 (%)
  • Figure 15. Heart Valve Stenosis: Europe Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 16. Heart Valve Regurgitation: Europe Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 17. Left Atrial Appendage Closure: Europe Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 18. Europe Structural Heart Market Revenue Share, by End User 2021 & 2028 (%)
  • Figure 19. Hospitals: Europe Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. Ambulatory Surgical Centers: Europe Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Cardiac Centers: Europe Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Europe Structural Heart Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 23. Europe Structural Heart Market, by Country, 2021 & 2028 (%)
  • Figure 24. Germany: Europe Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. UK: Europe Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 26. France: Europe Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. Italy: Europe Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. Spain: Europe Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. Rest of Europe: Europe Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
目次
Product Code: BMIRE00028942

The Europe structural heart market is expected to grow from US$ 3,213.80 million in 2022 to US$ 4,909.25 million by 2028. It is estimated to grow at a CAGR of 7.3% from 2022 to 2028.

Availability of Innovative Structural Heart Services Fuel Europe Structural Heart Market

The availability of technologically advanced products and treatment services allows surgeons, physicians, and other healthcare providers to offer superior services to their patients, which helps them maintain the optimum quality of life. The innovations are not limited to healthcare facilities, and they are extended to programs that are being designed for patients to get benefits out of treatment facilities. Heart diseases are complex, and the success of their intervention depends on innovations bringing treatment options that were deemed impossible earlier into reality. The heart disease treatment landscape-from structural inventions to surgical valve therapies-has experienced breakthrough innovations over the past few decades. Companies in the structural heart market offer a broad portfolio of solutions for different heart conditions, including vascular disease, irregular heartbeats, and heart valve diseases. Physicians can now manage arrhythmias by using remote monitoring devices to keep a tab on their patients, thereby treating an array of structural heart conditions.

The food and Drug Administration (FDA) have approved various therapies that are limited to the selected groups the patients. For instance, Premier Health, one of the providers of innovative structural heart services, offers alcohol septal ablation treatment for hypertrophic cardiomyopathy. The treatment mainly uses a catheter-based technology. The balloon valvuloplasty, uses a transcatheter approach for widening up stiff and narrow heart valves, atrial septal defect transcatheter repair which closes an opening between the heart's left and right atrium without surgery and such more services are being provided by the service providers. CentraCare's Heart & Vascular Center used EchoPixel's True3D and HTG pre-planning software, which provides mixed reality capabilities that allow structural heart care teams to interact with a real-time holographic version of the patient's anatomy without physically touching it or exposing it to contrast agents and radiations.

The innovative technologies and techniques of structural heart programs are specifically designed to provide quality care for the best results for patients and provides less complications and shorter recovery times with long-lasting advantages. Such technologies are likely to attract more patients suffering from the structural heart diseases and eventually the benefits of the services are likely to enhance the growth of the market in the forecasted period.

Europe Structural Heart Market Overview

The European structural heart market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region holds a significant market share in the structural heart market. The European structural heart market is expected to witness significant growth during the forecast period due to factors such as significant growth in elderly population, rise in the incidence of CVDs, and launch of innovative products by market players in the region. Also, there has been an increase in the number of product approvals for treating heart disease in Europe. Moreover, market players have undertaken a number of initiatives to attract a larger customer base and sustain the competitive nature of the market. All these factors are fueling the market growth in the region.

Europe Structural Heart Market Revenue and Forecast to 2028 (US$ Million)

Europe Structural Heart Market Segmentation

The Europe structural heart market is segmented int product, procedure, end user, and country.

Based on product, the Europe structural heart market is segmented into occluders, annuloplasty rings, heart valve balloons, and others. The occluders segment held the largest share of the Europe structural heart market in 2022.

Based on procedure, the Europe structural heart market is segmented into heart valve stenosis, heart valve regurgitation, and left atrial appendage closure. The heart valve stenosis segment held the largest share of the Europe structural heart market in 2022.

Based on end user, the Europe structural heart market is segmented into hospitals, ambulatory surgical centers, and cardiac centers. The hospitals segment held the largest share of the Europe structural heart market in 2022.

Based on country, the Europe structural heart market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe structural heart market in 2022.

Abbott Laboratories; Medtronic Plc; Boston Scientific Corp; Artivion Inc; Edwards Lifesciences Corp; Lepu Medical Technology Beijing Co Ltd; Braile Biomedical Industry, Commerce and Representations; and Micro Interventional Devices Inc are some of the leading companies operating in the Europe structural heart market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe structural heart market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in Europe structural heart market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Europe Structural Heart Market - by Product
    • 1.3.2 Europe Structural Heart Market - by Procedure
    • 1.3.3 Europe Structural Heart Market - by End User
    • 1.3.4 Europe Structural Heart Market - by Country

2. Europe Structural Heart Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Structural Heart Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Europe PEST Analysis
  • 4.3 Expert's Opinion

5. Europe Structural Heart Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Availability of Innovative Structural Heart Services
    • 5.1.2 Rising Number of Cardiovascular Disease Cases and Training Programs
  • 5.2 Key Market Restraints
    • 5.2.1 High Cost of Procedures
    • 5.2.2 Stringent Regulations Regarding Structure Heart Devices
  • 5.3 Key Market Opportunities
    • 5.3.1 Growing Use of Artificial Intelligence in Structural Heart
  • 5.4 Future Trends
    • 5.4.1 Technological Advancements in the Field of Structural Heart Devices
  • 5.5 Impact analysis

6. Europe Structural Heart Market -Europe Analysis

  • 6.1 Europe Structural Heart Market Revenue Forecast and Analysis

7. Europe Structural Heart Market - Revenue and Forecast to 2028 - by Product

  • 7.1 Overview
  • 7.2 Europe Structural Heart Market Revenue Share, by Product 2021 & 2028 (%)
  • 7.3 Occluders
    • 7.3.1 Overview
    • 7.3.2 Occluders: Europe Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Annuloplasty Rings
    • 7.4.1 Overview
    • 7.4.2 Annuloplasty Rings: Europe Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Heart Valve Balloons
    • 7.5.1 Overview
    • 7.5.2 Heart Valve Balloons: Europe Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others: Europe Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)

8. Europe Structural Heart Market - Revenue and Forecast to 2028 - by Procedure

  • 8.1 Overview
  • 8.2 Europe Structural Heart Market Revenue Share, by Procedure 2021 & 2028 (%)
  • 8.3 Heart Valve Stenosis
    • 8.3.1 Overview
    • 8.3.2 Heart Valve Stenosis: Europe Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Heart Valve Regurgitation
    • 8.4.1 Overview
    • 8.4.2 Heart Valve Regurgitation: Europe Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.5 Left Atrial Appendage Closure
    • 8.5.1 Overview
    • 8.5.2 Left Atrial Appendage Closure: Europe Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)

9. Europe Structural Heart Market - Revenue and Forecast to 2028 - by End User

  • 9.1 Overview
  • 9.2 Europe Structural Heart Market Revenue Share, by End User 2021 & 2028 (%)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 Hospitals: Europe Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Ambulatory Surgical Centers
    • 9.4.1 Overview
    • 9.4.2 Ambulatory Surgical Centers: Europe Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Cardiac Centers
    • 9.5.1 Overview
    • 9.5.2 Cardiac Centers: Europe Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)

10. Europe Structural Heart Market - Revenue and Forecast to 2028 -Country Analysis

  • 10.1 Overview
    • 10.1.1 Europe Structural Heart Market, by Country, 2021 & 2028 (%)
      • 10.1.1.1 Germany: Europe Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.1.1 Overview
        • 10.1.1.1.2 Germany: Europe Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.1.3 Germany: Europe Structural Heart Market, by Product, 2019-2028 (US$ Million)
        • 10.1.1.1.4 Germany: Europe Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
        • 10.1.1.1.4.1 Germany: Europe Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
        • 10.1.1.1.4.2 Germany: Europe Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
        • 10.1.1.1.5 Germany: Europe Structural Heart Market, by End User, 2019-2028 (US$ Million)
      • 10.1.1.2 UK: Europe Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 UK: Europe Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.2.3 UK: Europe Structural Heart Market, by Product, 2019-2028 (US$ Million)
        • 10.1.1.2.4 UK: Europe Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
        • 10.1.1.2.4.1 UK: Europe Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
        • 10.1.1.2.4.2 UK: Europe Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
        • 10.1.1.2.5 UK: Europe Structural Heart Market, by End User, 2019-2028 (US$ Million)
      • 10.1.1.3 France: Europe Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 France: Europe Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.3.3 France: Europe Structural Heart Market, by Product, 2019-2028 (US$ Million)
        • 10.1.1.3.4 France: Europe Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
        • 10.1.1.3.4.1 France: Europe Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
        • 10.1.1.3.4.2 France: Europe Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
        • 10.1.1.3.5 France: Europe Structural Heart Market, by End User, 2019-2028 (US$ Million)
      • 10.1.1.4 Italy: Europe Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.4.1 Overview
        • 10.1.1.4.2 Italy: Europe Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.4.3 Italy: Europe Structural Heart Market, by Product, 2019-2028 (US$ Million)
        • 10.1.1.4.4 Italy: Europe Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
        • 10.1.1.4.4.1 Italy: Europe Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
        • 10.1.1.4.4.2 Italy: Europe Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
        • 10.1.1.4.5 Italy: Europe Structural Heart Market, by End User, 2019-2028 (US$ Million)
      • 10.1.1.5 Spain: Europe Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.5.1 Overview
        • 10.1.1.5.2 Spain: Europe Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.5.3 Spain: Europe Structural Heart Market, by Product, 2019-2028 (US$ Million)
        • 10.1.1.5.4 Spain: Europe Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
        • 10.1.1.5.4.1 Spain: Europe Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
        • 10.1.1.5.4.2 Spain: Europe Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
        • 10.1.1.5.5 Spain: Europe Structural Heart Market, by End User, 2019-2028 (US$ Million)
      • 10.1.1.6 Rest of Europe: Europe Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.6.1 Overview
        • 10.1.1.6.2 Rest of Europe: Europe Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.6.3 Rest of Europe: Europe Structural Heart Market, by Product, 2019-2028 (US$ Million)
        • 10.1.1.6.4 Rest of Europe: Europe Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
        • 10.1.1.6.4.1 Rest of Europe: Europe Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
        • 10.1.1.6.4.2 Rest of Europe: Europe Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
        • 10.1.1.6.5 Rest of Europe: Europe Structural Heart Market, by End User, 2019-2028 (US$ Million)

11. Europe Structural Heart Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies
    • 11.2.1 Overview

12. Company Profiles

  • 12.1 Abbott Laboratories
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Medtronic Plc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Boston Scientific Corp
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Artivion Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Edwards Lifesciences Corp
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Lepu Medical Technology Beijing Co Ltd
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Aran Biomedical Teoranta
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Corcym UK Ltd
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments

13. Appendix

  • 13.1 About the Insight Partners
  • 13.2 Glossary of Terms